Related Experiment Videos
Altered systemic iron metabolism in Parkinson's disease
G Logroscino1, K Marder, J Graziano
1Gertrude H. Sergievsky Center, Department of Neurology, College of Physicians and Surgeons, New York, NY, USA.
Neurology
|September 26, 1997
Summary
Parkinson's disease patients show altered systemic iron metabolism, with lower iron, ferritin, and transferrin levels. This suggests a widespread regulatory defect affecting iron balance in both the brain and body.
Area of Science:
- Neuroscience
- Metabolic Disorders
- Iron Metabolism
Background:
- Iron accumulation in the substantia nigra is linked to Parkinson's disease (PD) pathology.
- This iron overload may exacerbate neurodegeneration through oxidative stress.
- Systemic iron metabolism in PD remains poorly understood.
Purpose of the Study:
- To investigate systemic iron metabolism in idiopathic Parkinson's disease.
- To compare iron-related markers between PD patients and healthy controls.
Main Methods:
- Measured serum iron, ferritin, transferrin, transferrin receptors, and total iron-binding capacity.
- Calculated transferrin saturation.
- Assessed dietary iron intake in PD patients and controls.
Main Results:
- PD patients exhibited significantly lower serum iron, ferritin, transferrin, and total iron-binding capacity.
- Transferrin saturation was also reduced in PD patients.
- No significant differences were observed in transferrin receptor levels or dietary iron intake.
Conclusions:
- Systemic iron dysregulation, characterized by reduced ferritin and transferrin, parallels brain iron changes in PD.
- Unexpected decreases in serum iron and transferrin saturation suggest a broader metabolic defect.
- This defect may impact iron regulation in both the liver and brain, potentially facilitating iron entry into the brain over time.